You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Janssen vaccine

Showing 1 - 25 of 8,350
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Covid19 Trial in Netherlands (Vaccination once with Janssen vaccine (only priming), Vaccination with Janssen vaccine followed

Recruiting
  • Covid19
  • Vaccination once with Janssen vaccine (only priming)
  • +3 more
  • Amsterdam, Netherlands
  • +3 more
Jun 26, 2021

Kidney Transplant Recipient Trial in Phoenix, Jacksonville, Rochester (Janssen Ad26.CoV2.S Vaccine, Reduction in

Recruiting
  • Kidney Transplant Recipient
  • Janssen Ad26.CoV2.S Vaccine
  • +2 more
  • Phoenix, Arizona
  • +2 more
Jul 14, 2022

Healthy Volunteers Trial in France (COVID-19 Vaccine Janssen (Ad26.COV2-S))

Recruiting
  • Healthy Volunteers
  • COVID-19 Vaccine Janssen (Ad26.COV2-S)
  • Dijon, France
  • +9 more
Apr 21, 2022

Immunogenicity of COVID-19 Vaccines in Tuberculosis Patients

Not yet recruiting
  • Covid-19 Pandemics
  • Tuberculosis
  • Pfizer-BioNTech COVID-19 vaccine
  • +2 more
  • Mae Sot, Tak, Thailand
    Shoklo Malaria Research Unit (SMRU)
Oct 21, 2022

Oxford-AstraZeneca COVID-19 Vaccine as2nd Booster,

Recruiting
  • COVID-19
  • ChAdOx1 nCOV-19 vaccine (Vaxzeria)
  • +3 more
  • São Paulo, Brazil
    Techtrials Pesquisa e Tecnologia Ltda.
Jan 23, 2023

Pancreatic Ductal Adenocarcinoma, Refractory NSCLC Trial in Washington (Daratumumab, KRAS vaccine, Nivolumab)

Not yet recruiting
  • Pancreatic Ductal Adenocarcinoma
  • Refractory Non-Small Cell Lung Cancer
  • Washington, District of Columbia
    Georgetown Lombardi Comprehensive Cancer Center
Sep 1, 2023

Covid19 Trial in Santander (Janssen vaccine, Spikevax (Moderna) vaccine)

Not yet recruiting
  • Covid19
  • Janssen vaccine
  • Spikevax (Moderna) vaccine
  • Santander, Cantabria, Spain
    Hospital Universitario Marqués de Valdecilla
Sep 16, 2021

Sars-CoV-2 Infection Trial in South Africa (Alveavax-v1.2, Janssen Ad26.COV2.S)

Completed
  • Sars-CoV-2 Infection
  • Bloemfontein, Free State, South Africa
  • +7 more
May 2, 2023

COVID-19 Trial in Las Piñas, Manila (Candidate vaccine, SCB-2019, Comirnaty Vaccine, COVID-19 Vaccine Janssen)

Recruiting
  • COVID-19
  • Candidate vaccine, SCB-2019
  • +3 more
  • Las Piñas, Metro Manila, Philippines
  • +1 more
Jul 10, 2022

SafeTy and Efficacy of Preventative CoVID Vaccines

Active, not recruiting
  • COVID-19 Virus Infection
  • Vaccine Response
  • mRNA Vaccines or Viral vector-based vaccines for COVID
  • Toronto, Ontario, Canada
    University Health Network
May 19, 2022

Second Booster Dose of Vaccine Against COVID-19 in Elderly

Not yet recruiting
  • COVID-19
  • +2 more
  • ChAdOx1 nCoV-19 or Comirnaty or Janssen COVID-19 Vaccine
  • Vitória, Espírito Santo, Brazil
    Valéria Valim
Mar 15, 2022

COVID-19, Vaccine Reaction, SARS CoV 2 Infection Trial in Bamako (Ad26.COV2.S, NVX-CoV2373)

Not yet recruiting
  • COVID-19
  • +3 more
  • Ad26.COV2.S
  • NVX-CoV2373
  • Bamako, Mali
    CVD-MALI
Jun 7, 2022

SARS-CoV-2 Infection Trial in Bangkok (Full dose of Ad26.COV2. 5x10^10vp, Half dose of Ad26.COV2. 2.5x10^10vp)

Recruiting
  • SARS-CoV-2 Infection
  • Full dose of Ad26.COV2. 5x10^10vp
  • Half dose of Ad26.COV2. 2.5x10^10vp
  • Bangkok, Thailand
    Vaccine Trial Centre, Faculty of Tropical Medicine, Mahidol Univ
Sep 11, 2022

Anaphylactic Reaction, Vaccine Reaction Trial in Paris (COVID-19 Vaccines)

Recruiting
  • Anaphylactic Reaction
  • Vaccine Reaction
  • COVID-19 Vaccines
  • Paris, France
    Tenon Hospital APHP dermatology and allergology department
Oct 15, 2021

BNT162b2 mRNA Covid-19 Vaccine in Brazil

Recruiting
  • Covid19
  • Pfizer/BioNTech BNT162b2 mRNA COVID-19 vaccine
  • +3 more
  • Toledo, Paraná, Brazil
    Pronto Atendimento Municipal de Toledo
Dec 14, 2021

Transverse Myelitis Related to SARS-CoV-2 Vaccines

Completed
  • Vaccine Adverse Reaction
  • SARS-CoV-2 vaccines
  • Caen, Basse Normandie, France
    Alexandre Joachim
Jan 3, 2022

Rheumatoid Arthritis, Systemic Lupus Erythematosus (SLE), Pemphigus Vulgaris Trial in United States (Moderna mRNA-1273,

Recruiting
  • Rheumatoid Arthritis
  • +8 more
  • Moderna mRNA-1273
  • +5 more
  • Los Angeles, California
  • +24 more
Aug 17, 2022

Ebola Virus Disease Trial in Kinshasa (Ad26.ZEBOV, MVA-BN-Filo vaccine)

Active, not recruiting
  • Ebola Virus Disease
  • Ad26.ZEBOV, MVA-BN-Filo vaccine
  • Kinshasa, Congo, The Democratic Republic of the
    L'Institut National de Recherche Biomédicale RDC
Nov 15, 2021

HIV, AIDS, Immunologic Deficiency Syndrome, Acquired Trial in Boston (Ad26.Mos4.HIV, MVA-BN-HIV, PGT121)

Recruiting
  • HIV
  • +4 more
  • Ad26.Mos4.HIV
  • +4 more
  • Boston, Massachusetts
    Beth Israel Deaconess Medical Center
Apr 18, 2022

Sustained Humoral and Cell-Mediated Immunogenicity of COVID-19

Not yet recruiting
  • Inflammatory Bowel Diseases
  • COVID-19 Vaccine
  • Jacksonville, Florida
  • +4 more
Aug 18, 2021

Ebola Virus Disease Trial in Entebbe (Ad26.ZEBOV/MVA-BN-Filo)

Completed
  • Ebola Virus Disease
  • Entebbe, Uganda
    MRC/UVRI & LSHTM Uganda Research Unit
May 10, 2021

SARS CoV 2 Infection Trial in South Africa (Booster vaccine)

Recruiting
  • SARS CoV 2 Infection
  • Booster vaccine
  • Mthatha, Eastern Cape, South Africa
  • +30 more
Jul 29, 2022

SARS (Severe Acute Respiratory Syndrome) Trial in South Africa (To monitor the effectiveness of the single dose Ad26.COV2.S

Completed
  • SARS (Severe Acute Respiratory Syndrome)
  • To monitor the effectiveness of the single dose Ad26.COV2.S COVID-19 vaccine
  • Mthatha, Eastern Cape, South Africa
  • +30 more
Jul 29, 2022

COVID-19, SARS-CoV-2 Acute Respiratory Disease Trial in Italy, Portugal, Spain (COVID-19 Vaccine 40 ug/dose)

Recruiting
  • COVID-19
  • SARS-CoV-2 Acute Respiratory Disease
  • COVID-19 Vaccine 40 ug/dose
  • Milano, Italy
  • +19 more
Jul 19, 2022

COVID-19 Trial in United States (Ad26.COV2.S, BNT162b2, mRNA-1273)

Recruiting
  • COVID-19
  • Ad26.COV2.S
  • +4 more
  • Atlanta, Georgia
  • +11 more
Aug 11, 2022